1. Home
  2. NSYS vs MRKR Comparison

NSYS vs MRKR Comparison

Compare NSYS & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nortech Systems Incorporated

NSYS

Nortech Systems Incorporated

HOLD

Current Price

$9.05

Market Cap

25.5M

Sector

Technology

ML Signal

HOLD

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.56

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSYS
MRKR
Founded
1981
N/A
Country
United States
United States
Employees
744
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.5M
24.5M
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
NSYS
MRKR
Price
$9.05
$1.56
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$10.17
AVG Volume (30 Days)
5.0K
202.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,371,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.01
N/A
52 Week Low
$6.50
$0.81
52 Week High
$12.40
$4.07

Technical Indicators

Market Signals
Indicator
NSYS
MRKR
Relative Strength Index (RSI) 52.64 48.80
Support Level $8.86 $1.37
Resistance Level $9.82 $1.88
Average True Range (ATR) 0.45 0.12
MACD -0.08 0.00
Stochastic Oscillator 53.42 54.02

Price Performance

Historical Comparison
NSYS
MRKR

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: